Agribio Spirits Posts Strong FY26 Results with 147% Revenue Jump

Standalone Revenue: ₹44.9975 crore | Consolidated Net Profit: ₹4.0272 crore

Reader Takeaway: Strong revenue growth and dividend payout are positive, but merger approval is a key concern.

What just happened

Agribio Spirits Limited announced its financial results for the fiscal year ended March 31, 2026. The company reported a significant increase in standalone revenue, which grew by approximately 147% to ₹44.9975 crore from ₹18.1898 crore in the previous year. Standalone net profit saw a modest increase from ₹1.1446 crore to ₹1.2448 crore. On a consolidated basis, net profit improved to ₹4.0272 crore from ₹3.6629 crore.

The Board of Directors recommended a final dividend of ₹0.30 per share. Additionally, the company acquired a 100% stake in Solkit Distillery and Brewery Private Limited, effective September 15, 2025.

Why this matters

The substantial revenue growth indicates Agribio Spirits' expanding market presence and successful scaling of operations. The recommended dividend offers a direct return to shareholders. The acquisition of Solkit Distillery suggests strategic expansion in its business segment. However, the company's proposed merger with Agribiotech Industries Limited is still awaiting approval from the National Company Law Tribunal (NCLT), which remains a critical factor for its future corporate structure.

The backstory

Agribio Spirits Limited is involved in the manufacturing of spirits and related products. The company has been working on strategic initiatives, including a merger with Agribiotech Industries. The acquisition of Solkit Distillery is a recent move to bolster its operational capabilities.

What changes now

Shareholders can expect a dividend payout if approved. The acquisition of Solkit Distillery is now integrated into the company's operations. The focus will shift to the NCLT's decision on the Agribiotech Industries merger, which could significantly alter the company's structure and scale.

Risks to watch

The primary risk is the dependency on the NCLT approval for the merger with Agribiotech Industries. Any delay or unfavorable ruling could impact the intended synergies and restructuring. The integration of Solkit Distillery also needs to be monitored for successful operational synergy.

Peer comparison

Agribio Spirits' revenue growth in FY26 is significantly higher than many players in the spirits industry, which typically see single to double-digit growth. The consolidated profit margins are comparable to industry averages, but the aggressive top-line expansion is a notable differentiator. The dividend payout is a common practice among established players.

Context metrics (time-bound)

• Standalone Revenue FY26: ₹44.9975 crore (vs. ₹18.1898 crore in FY25)
• Standalone Net Profit FY26: ₹1.2448 crore (vs. ₹1.1446 crore in FY25)
• Consolidated Net Profit FY26: ₹4.0272 crore (vs. ₹3.6629 crore in FY25)
• Dividend Recommended: ₹0.30 per share
• Acquisition of Solkit Distillery: Effective September 15, 2025
• Merger with Agribiotech Industries: Pending NCLT approval

What to track next

Investors should closely monitor the NCLT proceedings regarding the Agribiotech Industries merger. The performance of the newly acquired Solkit Distillery and its contribution to consolidated results will also be important. Further updates on the company's strategic initiatives and market performance in the upcoming quarters should be tracked.